IL156990A0 - Identification and cloning of a novel human gene ret16 - Google Patents

Identification and cloning of a novel human gene ret16

Info

Publication number
IL156990A0
IL156990A0 IL15699002A IL15699002A IL156990A0 IL 156990 A0 IL156990 A0 IL 156990A0 IL 15699002 A IL15699002 A IL 15699002A IL 15699002 A IL15699002 A IL 15699002A IL 156990 A0 IL156990 A0 IL 156990A0
Authority
IL
Israel
Prior art keywords
ret16
cloning
identification
human gene
novel human
Prior art date
Application number
IL15699002A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL156990A0 publication Critical patent/IL156990A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15699002A 2001-02-16 2002-02-15 Identification and cloning of a novel human gene ret16 IL156990A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26936601P 2001-02-16 2001-02-16
US29418101P 2001-05-29 2001-05-29
PCT/US2002/005162 WO2002066494A2 (en) 2001-02-16 2002-02-15 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade

Publications (1)

Publication Number Publication Date
IL156990A0 true IL156990A0 (en) 2004-02-08

Family

ID=26953655

Family Applications (5)

Application Number Title Priority Date Filing Date
IL15699002A IL156990A0 (en) 2001-02-16 2002-02-15 Identification and cloning of a novel human gene ret16
IL156990A IL156990A (en) 2001-02-16 2003-07-17 Identification and cloning of a novel human gene ret16
IL184513A IL184513A (en) 2001-02-16 2007-07-10 Purified cell signaling proteins and pharmaceutical compositions containing the same
IL190471A IL190471A (en) 2001-02-16 2008-03-27 Method of screening for compounds which inhibit binding of a human cell signaling protein with a second cell signaling protein
IL190470A IL190470A0 (en) 2001-02-16 2008-03-27 A method of identifying compounds that inhibit the phosphorylation of a cell signaling cascade protein

Family Applications After (4)

Application Number Title Priority Date Filing Date
IL156990A IL156990A (en) 2001-02-16 2003-07-17 Identification and cloning of a novel human gene ret16
IL184513A IL184513A (en) 2001-02-16 2007-07-10 Purified cell signaling proteins and pharmaceutical compositions containing the same
IL190471A IL190471A (en) 2001-02-16 2008-03-27 Method of screening for compounds which inhibit binding of a human cell signaling protein with a second cell signaling protein
IL190470A IL190470A0 (en) 2001-02-16 2008-03-27 A method of identifying compounds that inhibit the phosphorylation of a cell signaling cascade protein

Country Status (8)

Country Link
US (2) US7198911B2 (de)
EP (1) EP1575984A4 (de)
JP (1) JP2004532619A (de)
AU (1) AU2002250151B2 (de)
CA (1) CA2438369A1 (de)
IL (5) IL156990A0 (de)
MX (1) MXPA03007275A (de)
WO (1) WO2002066494A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6114517A (en) * 1998-12-10 2000-09-05 Isis Pharmaceuticals Inc. Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
EP1196575A2 (de) 1999-07-19 2002-04-17 Incyte Genomics, Inc. An gtp-bindende proteine assoziierte faktoren
CN1300734A (zh) 1999-12-21 2001-06-27 复旦大学 一种新的多肽－Beta－转导素41和编码这种多肽的多核苷酸
CA2402563A1 (en) 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
US6569662B1 (en) * 2000-01-21 2003-05-27 Hyseq, Inc. Nucleic acids and polypeptides
JP2004509894A (ja) * 2000-09-20 2004-04-02 ファルマシア・アンド・アップジョン・カンパニー 置換アゼピノ［４，５−ｂ］インドリン誘導体
US6849640B2 (en) * 2001-08-08 2005-02-01 Pharmacia & Upjohn Company Therapeutic 1H-pyrido [4,3-b] indoles
WO2004056324A2 (en) * 2002-12-19 2004-07-08 Bristol-Myers Squibb Company Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists

Also Published As

Publication number Publication date
MXPA03007275A (es) 2003-12-04
CA2438369A1 (en) 2002-08-29
US20020187492A1 (en) 2002-12-12
EP1575984A4 (de) 2006-09-06
WO2002066494A2 (en) 2002-08-29
JP2004532619A (ja) 2004-10-28
US7678887B2 (en) 2010-03-16
IL190470A0 (en) 2008-11-03
IL184513A0 (en) 2007-10-31
WO2002066494A8 (en) 2003-10-23
AU2002250151B2 (en) 2007-08-16
WO2002066494A3 (en) 2005-12-08
IL190471A0 (en) 2008-11-03
IL184513A (en) 2010-04-15
IL156990A (en) 2008-12-29
US7198911B2 (en) 2007-04-03
IL190471A (en) 2010-12-30
US20070142294A1 (en) 2007-06-21
EP1575984A2 (de) 2005-09-21

Similar Documents

Publication Publication Date Title
AU2002314417A1 (en) Identification and characterization of plant genes
AU2002318209A1 (en) Identification and use of conserved noncoding sequences
IL150468A0 (en) Improved micro-needles and methods of manufacture and use thereof
EP1466982A4 (de) Pyroglutamylpeptidase und ihr gen
GB0416088D0 (en) Methods of parallel gene cloning and analysis
GB0123961D0 (en) Process and intermediates
AU2002365202A8 (en) Synthetic genes for malarial proteins and methods of use
IL162206A0 (en) Production of chirally pure-aminoacid and n-sulfo nyl amino acids
GB0123401D0 (en) Methods of inducing gene expression
AU2002341927A8 (en) Detection and identification of enteric bacteria
AU2002325266A1 (en) Identification and characterization of plant genes
ZA200510465B (en) Use of a novel eimeria gene and corresponding protein
EP1408985A4 (de) Neue pyridopyrimidone und ihre verwendungszwecke
GB0214647D0 (en) Method of simplifying commodity picking
AU2002314742A1 (en) Identification and enumeration of coccidial sporocysts
GB0127657D0 (en) Virulence genes and proteins and their use
IL161608A0 (en) Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
AU2002351616A8 (en) Lipase genes and proteins
EP1392460A4 (de) Fluorwasserstoffe von aminosilanolen und ihre verwendung
AU2002331369A1 (en) Identification of human auto-antibodies
AUPR701801A0 (en) Identification and selection of genes
GB0114403D0 (en) Identification of genes
GB0102447D0 (en) Protein variants and uses thereof
EP1575984A4 (de) "identifizierung und klonierung eines neuen humanen gens, ret 16, das an der intrazellul ren signalkaskade beteiligt ist"
GB0112453D0 (en) Interferon-alpha induced gene